News | May 13, 2025
Morepen Board proposed dividend after 23 years
Scores highest PAT of Rs. 118 crore in FY25
Scores highest PAT of Rs. 118 crore in FY25
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
Puri is an accomplished leader and financial sector veteran with over four decades of experience
With the addition of Karsanbhai, the Merck board will consist of 13 members
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
Subscribe To Our Newsletter & Stay Updated
